AI-powered search
AI-powered search

On-Demand CME Videos

5 Tips on Therapeutic Options in Vitiligo Treatment: An Evolving Landscape: An Online Activity

About

This 10-minute microlearning discussion is designed to provide "5 practical tips" on improving clinical care for vitiligo patients that you can incorporate into clinical practice. Learn through short bursts of information focused on clinical diagnosis, disease burden, patient-centered management and treatment timing.

This activity is supported by an educational grant from Incyte.

Availability

In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

May 8, 2024

Expiration Date:

May 13, 2025

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Describe strategies to individualize care when using emerging therapies for vitiligo

  • Identify techniques for incorporating emerging vitiligo therapies into everyday practice

Intended Audience

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

Faculty
Andrew
Andrew Alexis, MD, MPH

Vice-Chair for Diversity and Inclusion, Dept. of Dermatology
Professor of Clinical Dermatology 
Weill Cornell Medicine
New York, NY

David
David Rosmarin, MD

Vice Chair of Education and Research
Tufts Medical Center
Boston, MA

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

Andrew F. Alexis, MD, MPH

Grant/Research Support: BMS, LEO, Novartis, Almirall

Consultant: Leo, Galderma, Pfizer, Sanofi- Regeneron

Speakers’ Bureau or Honoraria: Regeneron, SANOFI-Genzyme, Pfizer, BMS

David Rosmarin, MD

No relevant financial relationship with any Ineligible Company in the past 24 months.

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.


Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved